The purpose of Idorsia is the discovery of more, innovative medicines. We have more ideas, we see more opportunities and we want to help more patients.
In order to achieve this we will develop Idorsia into one of Europe’s leading biopharmaceutical companies, with a strong scientific core.
Located in Switzerland - a biotech-hub of Europe - Idorsia is specialized in the discovery and development of small molecules, to transform the horizon of therapeutic options.
Find out more about the key priorities that management has set in order to develop Idorsia into one of Europe’s leading biopharmaceutical companies.
Idorsia has a diversified clinical development pipeline in multiple therapeutic areas, including central nervous system disorders, cardiovascular disorders, immunological disorders, and orphan diseases.
Corporate Governance & Sustainability
Sound corporate governance and high standards of ethical behavior are essential to company success, and in maintaining the trust and confidence of our stakeholders.